2015
DOI: 10.1016/j.transproceed.2015.03.025
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcomes and Genetic Expression Profile in Human Liver Graft Dysfunction During Ischemia/Reperfusion Injury

Abstract: Introduction. This study aims to compare the molecular gene expression during ischemia reperfusion injury. Several surgical times were considered: in the beginning of the harvesting (T0), at the end of the cold ischemia period (T1), and after reperfusion (T2) and compared with graft dysfunction after liver transplant (OLT). Methods. We studied 54 patients undergoing OLT. Clinical, laboratory data, and histologic data (Suzuki classification) as well as the Survival Outcomes Following Liver Transplantation (SOFT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Liver transplantation is the standard therapy for end-stage liver disease 1 . At present, almost all transplanted livers suffer ischemia during cold preservation and subsequent reperfusion injury 2 , posing a huge challenge to the functional recovery of donor livers and the prognosis of recipients. The mechanism involved in ischemia–reperfusion injury (IRI) is complex, including changes in a variety of cellular components, inflammatory factors, and mediators 3 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Liver transplantation is the standard therapy for end-stage liver disease 1 . At present, almost all transplanted livers suffer ischemia during cold preservation and subsequent reperfusion injury 2 , posing a huge challenge to the functional recovery of donor livers and the prognosis of recipients. The mechanism involved in ischemia–reperfusion injury (IRI) is complex, including changes in a variety of cellular components, inflammatory factors, and mediators 3 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Liver transplantation is the standard therapy for end-stage liver disease 1 . At present, almost all transplanted livers suffer ischemia during cold preservation and subsequent reperfusion injury 2 , posing a huge challenge to the functional recovery of donor livers and the prognosis of recipients. The mechanism involved in ischemia-reperfusion injury (IRI) is complex, including changes in a variety of cellular components, inflammatory factors and mediators [3][4][5] .…”
Section: Introductionmentioning
confidence: 99%